We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
(Approval lapsed) XYLOCAINE 2% with EPINEPHRINE 1:200,000 - lidocaine hydrochloride and epinephrine injection USP 20mL single use vial (Aspen Canada)
Section 19A approved medicine
(Approval lapsed) XYLOCAINE 2% with EPINEPHRINE 1:200,000 - lidocaine hydrochloride and epinephrine injection USP 20mL single use vial (Aspen Canada)
Section 19A approval holder
Pro Pharmaceuticals Group Pty Ltd ABN 20 605 457 430
Phone
1300 077 674
Approved until
Status
Expired
Medicines in short supply/unavailable
Xylocaine 2.0% with adrenaline (epinephrine) 1:200,000 20mL injection vial - ARTG -12021
Indication(s)
Indicated for the production of local or regional anaesthesia by the following techniques:
- infiltration,
- intravenous regional anaesthesia - excluding solutions with adrenaline (epinephrine) acid tartrate,
- peripheral nerve block such as intercostal block,
- major plexus block such as brachial plexus block,
- epidural block,
- subarachnoid block.
Images
